1.
Mohammad Alabdali M, Rafique N, AlDossary DA, Alalloush RS, AlHemli HA, Zeerak M, et al. Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients. J Clin Med Res [Internet]. 2024 Nov. 30 [cited 2024 Dec. 26];16(11):527-35. Available from: https://jocmr.elmerjournals.com/jocmr/article/view/6054